Aug 13, 2026 04:05PM
Jun 16, 2026 06:48AM
Jun 12, 2026 08:10AM
Jun 11, 2026 08:02AM
Jun 11, 2026 08:01AM
Jun 11, 2026 08:01AM
Jun 11, 2026 08:00AM Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
May 12, 2026 09:30AM
May 7, 2026 04:05PM
Mar 31, 2026 08:05AM
Mar 31, 2026 08:00AM
Mar 6, 2026 12:51PM
Mar 5, 2026 04:05PM
Feb 4, 2026 08:00AM Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
Dec 24, 2025 06:00AM
Dec 24, 2025 06:00AM
Dec 1, 2025 04:05PM
Nov 13, 2025 04:47AM
Nov 12, 2025 04:05PM
Nov 3, 2025 07:02AM
Nov 3, 2025 07:01AM Caribou Biosciences reports positive ANTLER trial data for vispa-cel
Nov 3, 2025 07:00AM
Nov 3, 2025 07:00AM
Nov 2, 2025 04:00PM
Aug 12, 2025 04:05PM
May 8, 2025 04:05PM
Apr 24, 2025 04:16PM
Apr 24, 2025 04:15PM Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
Mar 10, 2025 04:05PM
Jan 12, 2025 07:05PM
Nov 6, 2024 04:05PM
Sep 25, 2024 09:00AM
Sep 4, 2024 07:29AM
Sep 3, 2024 08:01AM
Sep 3, 2024 08:00AM Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML
Aug 12, 2024 08:04AM
Aug 12, 2024 08:00AM
Aug 6, 2024 04:05PM
Jul 9, 2024 08:04AM
Jul 9, 2024 08:00AM
Jun 3, 2024 06:25AM
Jun 2, 2024 07:00PM Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 13, 2024 07:00AM
May 7, 2024 04:05PM
Apr 27, 2024 06:00AM
Apr 24, 2024 10:00AM
Apr 4, 2024 04:00PM
Apr 4, 2024 04:00PM
Mar 27, 2024 06:45AM Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Mar 11, 2024 04:05PM

329,980 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All